| Patent application number | Description | Published |
|---|
| 20090004213 | COMBINATION THERAPY USING ACTIVE IMMUNOTHERAPY - The present invention relates to methods of treating cancer in a mammal comprising administering to the mammal a combination therapy comprising a vaccine and a multi-kinase inhibitor, wherein the vaccine comprises an isolated tumor associated peptide having the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I or class-II. Preferably the multi-kinase inhibitor is sunitinib malate and/or sorafenib tosylate or a pharmaceutically acceptable salt thereof. | 01-01-2009 |
| 20090123489 | NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 05-14-2009 |
| 20090136528 | NOVEL IMMUNOGENIC EPITOPE FOR IMMUNOTHERAPY - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumour cells which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 05-28-2009 |
| 20090148400 | COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer. | 06-11-2009 |
| 20090274714 | TUMOUR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINE - The present invention relates to immunotherapeutic methods, and molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the present invention relates to two novel peptide sequences derived from HLA class II molecules of human tumour cell lines, which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 11-05-2009 |
| 20100158931 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 06-24-2010 |
| 20110002963 | COMPOSITION OF TUMOR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE FOR THE TREATMENT OF GLIOBLASTOMA (GBM) AND OTHER CANCERS - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gliomas. | 01-06-2011 |
| 20110117117 | NOVEL IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumour cells which can be used in vaccine compositions for eliciting anti-tumour immune responses. | 05-19-2011 |
| Patent application number | Description | Published |
|---|
| 20080306902 | SYSTEM AND METHOD FOR TRACKING PRINT JOB STATUS - A system and method to track and display the status of an electronic document submitted through a web-portal to a multifunctional peripheral device. The multifunctional peripheral device receives an electronic document file upon which it is to perform a service and logs the receipt in a central status database. During the processing of the electronic document file, the multifunctional peripheral device continually updates the status information corresponding to that file in the central status database. Through a web-portal, a user selects from a list of recently submitted document files one file for which status information is desired. The multifunctional peripheral device then accesses the central status database, retrieves the file, and displays, via the web-portal, detailed document and status information corresponding to the selected document file. | 12-11-2008 |
| 20090158152 | SYSTEM AND METHOD FOR GENERATING CONTEXT SENSITIVE HELP FOR A GRAPHICAL USER INTERFACE - The subject application is directed to a system and method for generating context sensitive help for a graphical user interface. Display data corresponding to a plurality of indicia is first generated on an associated display, each indicia corresponding to a functionality of an associated information processing device. Selection data is then received corresponding to a selected indicia from those displayed. A touch down signal is then received corresponding to a tactile exertion of positive physical pressure. Duration data representing the duration of the exerted positive physical pressure is then received. A display of data associated with the functionality of the information processing device is subsequently triggered in accordance with the selected indicia corresponding to the received selection data and the received duration data. | 06-18-2009 |
| 20090204644 | SYSTEM AND METHOD FOR ON-DEMAND GENERATION OF A SELECTABLE INPUT FOR ENACTING A PREVIOUS DOCUMENT PROCESSING DEVICE CONTROL SEQUENCE - The subject application is directed to a system and method for on-demand generation of a selectable input for enacting a previous document processing device control sequence. User identification data is received, and a document processing session is opened. A sequence of instructions is then received, and data associated with the sequence is logged according to identification data. After the session opening, logged data is stored in associated memory. Data of a request to generate a selectable input corresponding to the logged data is then received, and testing is performed to determine whether data has been logged in a current session. Data logged during the session is associated with the selectable input, and stored data is retrieved and associated with the selectable input when no data has been logged during the current session. The sequence of selected instructions is then commenced upon the selection of the selectable input by the user. | 08-13-2009 |
| 20090300484 | SYSTEM AND METHOD FOR LOCAL MODIFICATION OF REMOTELY SUBMITTED DOCUMENT PROCESSING JOBS - The subject application is directed to rendering a remotely submitted document processing job using secondary job processing parameters specified at the rendering device. Electronic document data, associated identification data, and initial instruction data is received via a remote client interface. Location data of a selected rendering device is received via the remote interface, and the received job data is stored in a data storage associated with the device. The device's local interface receives login data, which is tested against the identification data. A display is selectively generated of the instruction and document data based on the testing output. Modified instruction data is received via the local interface relative to the initial instruction data. The costs for rendering the document data via the device are then calculated and displayed on the local interface. Following receipt of approval data via the local interface, a rendering operation is commenced on the document data. | 12-03-2009 |
| Patent application number | Description | Published |
|---|
| 20090247725 | Methods for Preparing Oxydiphthalic Anhydrides, Oxydiphthalic Anhydrides Prepared Thereby, and Polyetherimides Derived Therefrom - a method for preparing an oxydiphthalic anhydride comprises contacting, under reactive and substantially anhydrous conditions in a reactor, at least one halophthalic anhydride containing more than 250 ppm chlorophthalide impurity with a carbonate of the formula M | 10-01-2009 |
| 20090247727 | Method of Purifying Dianhydrides, the Dianhydrides Formed Thereby, and Polyetherimides Formed Therefrom - A method for purifying an oxydiphthalic anhydride comprises diluting a first mixture comprising an oxydiphthalic anhydride, a solvent, a catalyst, and an inorganic salt with a solvent, to provide a second mixture having a solids content of 10 to 30 percent based on total weight of the second mixture; filtering and washing the solids of the second mixture at a temperature below the crystallization point temperature of the oxydiphthalic anhydride to provide a third mixture; hydrolyzing the third mixture by adding water and a water-soluble acid to form a fourth mixture; heating the fourth mixture; then cooling to provide a solid-liquid mixture, optionally decanting a portion of the liquid, rediluting the remaining solid-liquid mixture, then filtering to provide a solid component; washing the solid component with water to provide a fifth mixture of oxydiphthalic tetraacid and water; ring closing the oxydiphthalic tetraacid to provide oxydiphthalic anhydride, and filtering the oxydiphthalic anhydride. | 10-01-2009 |
| Patent application number | Description | Published |
|---|
| 20110229504 | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer - The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses. | 09-22-2011 |
| 20110229505 | Methods for the diagnosis and treatment of cancer based on AVL9 - The present invention relates to methods for the diagnosis and treatment of cancer in mammals, in particular gastric cancer, based on the new target AVL9. The present invention thus relates to diagnostic methods and related components to be used in such methods. Furthermore, the present invention relates to the treatment of cancer in mammals, in particular gastric cancer, based on AVL9 as a target. Specifically, the present invention relates to the immunotherapy of cancer using AVL9 tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides, and respective pharmaceutical compositions, in particular vaccine compositions. | 09-22-2011 |
| 20110229524 | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of Gastric Cancer and other cancers - The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gastric cancers (GC). | 09-22-2011 |
